Sernova and Evotec Enter into an Exclusive Global Strategic Partnership for iPSC-Based Beta Cell Replacement Therapy to Develop and Commercialize a ‘Functional Cure’ for Diabetes

Sernova Corp. and Evotec SE announced an exclusive global strategic partnership to develop a best-in-class cell therapy treatment for people living with insulin-dependent diabetes.